The in vitro and in vivo effect of chemotherapeutic agents on the Marek's disease herpesvirus of chickens.
D000284:Administration, Oral; D000577:Amides / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000998:Antiviral Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D002478:Cells, Cultured; D002645:Chickens; D003588:Cytopathogenic Effect, Viral; D003622:Dapsone / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D005347:Fibroblasts; D006564:Herpesviridae / Q000187:drug effects* / Q000254:growth & development / Q000302:isolation & purification; D007279:Injections, Subcutaneous; D008380:Marek Disease / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D012263:Ribonucleosides / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D014230:Triazoles / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D014508:Urea / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D010948:Viral Plaque Assay
D000577:Amides; D000998:Antiviral Agents; D012263:Ribonucleosides; D014230:Triazoles; D003622:Dapsone; D014508:Urea